Kotak has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Torrent Pharmaceuticals to report net profit at Rs. 199.3 crore down 12.6% year-on-year (down 19% quarter-on-quarter).
Net Sales are expected to increase by 14.7 percent Y-o-Y (down 3.7 percent Q-o-Q) to Rs. 1,975.8 crore, according to Kotak.
Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 46.7 percent Y-o-Y (down 4.8 percent Q-o-Q) to Rs. 533.9 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Kotak - All Sectors Q4 Estimates
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
